The cytoplasmic Elmo1:Dock180 complex acts as a guanine nucleotide exchange factor (GEF) for the small GTPase Rac and functions downstream of the phagocytic receptor BAI1 during apoptotic cell clearance, and in the entry of Salmonella and Shigella into cells [1] [2] [3] [4] [5] [6] [7] . We discovered an unexpected binding between Elmo1 and the Mediator complex subunit Med31. The Mediator complex is a regulatory hub for nearly all gene transcription via RNA polymerase II, bridging the general transcription machinery with gene-specific regulatory proteins [8] [9] [10] [11] [12] [13] [14] . Med31 is the smallest and the most evolutionarily conserved Mediator subunit [15, 16] , and knockout of Med31 results in embryonic lethality in mice [17] ; however, Med31 function in specific biological contexts is poorly understood. We observed that in primary macrophages, during Salmonella infection, Elmo1 and Med31 specifically affected expression of the cytokine genes Il10 and Il33 among the >25 genes monitored. Although endogenous Med31 is predominantly nuclear localized, Elmo1 increased the cytoplasmic localization of Med31. We identify ubiquitination as a novel posttranslational modification of Med31, with the cytoplasmic monoubiquitinated form of Med31 being enhanced by Elmo1. These data identify Elmo1 as a novel regulator of Med31, revealing a previously unrecognized link between cytoplasmic signaling proteins and the Mediator complex.
Results and Discussion

Elmo1 Binds the Mediator Complex Subunit Med31
In a yeast two-hybrid screen in which full-length murine Elmo1 (amino acids 1-727) ( Figure 1A ) was used as bait, we unexpectedly identified Med31 as a binding partner from a 7-day mouse embryo library ( Figure 1B ). The Elmo1:Med31 interaction was confirmed in mammalian cells, where Med31 coprecipitated full-length Elmo1 from lysates ( Figure 1C ) under a variety of salt and detergent concentrations (see Figure S1A available online), suggesting a stable interaction. Elmo1 binding to Med31 also occurred at endogenous levels of Med31 ( Figure S1B ). Further mapping of the interaction in the yeast two-hybrid system and in mammalian cells revealed that Med31 interacts with the C-terminal portion (amino acids 532-727) of Elmo1, but not the N-terminal regions ( Figures 1B and 1C) . Deletion of the C-terminal 20 amino acids of Elmo1 (1-707), which contains a PxxP motif, failed to bind Med31 ( Figure 1C ). Proline-to-alanine mutations within the PxxP motif of full-length Elmo1 (Elmo1 AxxA) abrogated the Elmo1-Med31 binding ( Figure 1D ), suggesting a critical role for this PxxP motif. These observations suggested a novel and unexpected interaction between a predominantly nuclear protein, Med31, and a cytoplasmic signaling protein, Elmo1.
Elmo1 Binds the Same Region of Med31 Involved in Binding to Med7
The structure of yeast Med31, cocrystallized with the N-terminal region of another Mediator subunit, Med7 (Med7N), revealed that the hydroxyl groups of two evolutionarily conserved tyrosine residues in Med31 (Y33 and Y63) were in close proximity to proline-rich regions of Med7N [16] (Figure S3 ). To test whether Med31 might use these tyrosines to bind the PxxP motif of Elmo1, we introduced phenylalanine substitutions (Y33F or Y63F) into murine Med31. The Y33F mutant, but not the Y63F mutant, retained the ability to coprecipitate Elmo1 ( Figure 1E ). These data identified Y63 in Med31 and the PxxP motif within Elmo1 as key components of the interaction and suggested that other proline-rich containing proteins can replace Med7N in binding to Med31.
Elmo1:Med31 Interaction Is Distinct from the Elmo1:Dock180 Complex
To date, all of the functions associated with Elmo1 in mammalian and Caenorhabditis elegans models are mediated through its interaction with the large protein Dock180, with the Elmo1: Dock180 complex functioning as a bipartite GEF for the GTPase Rac [18] . We asked whether Med31 might be part of the Elmo1:Dock180 complex. Whereas Elmo1 could readily associate with either Med31 or Dock180 ( Figure 1F , lanes 5, 9, 11, and 15), Med31 did not bind Dock180, nor was it part of the Elmo1:Dock180 complex ( Figure 1F, lanes 6, 8, 10 , 12, 14, and 16). When all three proteins were coexpressed, Elmo1 appeared to favor Dock180 binding over Med31 (Figure 1F, lanes 8, 12, and 16 ). These data suggest that the Elmo1:Med31 complex is distinct from the Elmo1:Dock180 complex.
As a corollary, we asked whether Elmo1 might associate with the Med31:Med7 subcomplex. Whereas Med31 could associate independently with both Elmo1 ( Figure 1G , lanes 5 and 9) and Med7 ( Figure 1G, lanes 6 and 14) , Elmo1 was not found in the same complex with Med7 when coexpressed with or without Med31 ( Figure 1G ). Although qualitative, when all three proteins were overexpressed, Med31 appeared to favor binding Med7 over Elmo1 ( Figure 1G, lanes 8, 12, and  16 ). These data suggest that the Elmo1:Med31 complex is distinct from the Med31:Med7 complex and, by extrapolation, the larger Mediator complex.
Elmo1 Promotes Relocalization of Med31 from the Nucleus to the Cytoplasm
Med31 is thought to be a predominantly nuclear protein. Consistent with this, we observed by fluorescence microscopy that endogenous Med31 was largely nuclear localized ( Figures  2A-2C ), though faint cytoplasmic localization was reproducibly detected. Additionally, overexpressed Med31 was also primarily nuclear localized ( Figures 2J-2L) . Surprisingly, expression of Elmo1 in cells resulted in increased cytoplasmic localization of endogenous Med31 ( Figures 2D-2F ) in 85% of Elmo1-expressing cells. In contrast, expression of the Elmo1 AxxA mutant, which does not bind Med31, did not affect the subcellular localization of endogenous Med31 (Figures 2G-2I ). Elmo1 also resulted in increased cytoplasmic localization of overexpressed Med31 ( Figures 2M-2O ). The C-terminal portion of Elmo1 (532-727), which is sufficient to bind Med31, also resulted in cytoplasmic translocation of Med31 ( Figures 2P-2R ). Med31 remained largely nuclear when Biochemical fractionation studies also revealed that Elmo1 was largely cytoplasmic, with minimal detection in nuclear extracts ( Figure 2Y , lanes 6, 8, 10, and 12). However, Med31 was detectable in both nuclear and cytoplasmic fractions ( Figure 2Y, lanes 7, 8,  11 , and 12), consistent with the immunofluorescence imaging (Figures 2J-2O ). The level of Med31 in the cytoplasmic fraction increased in the presence of Elmo1. These data suggest that the Elmo1:Med31 interaction occurs predominantly in the cytoplasm. To our knowledge, this is the first demonstration of a cytoplasmic binding partner of Med31.
Mice and humans express three Elmo homologs, Elmo1, Elmo2, and Elmo3. Elmo1 is ubiquitously expressed, with enriched expression in cells of the monocyte/macrophage lineage, whereas Elmo2 and Elmo3 have more restricted expression patterns [1] . Elmo1 and Elmo2 readily associated with Med31, whereas Elmo3 did not bind Med31 ( Figure S2A ). Consistent with this result, coexpression of Med31 with Elmo1 or Elmo2 resulted in increased cytoplasmic localization of Med31 ( Figures S2E-S2J ), whereas coexpression with Elmo3 did not ( Figures S2K-S2M) . Collectively, these data reveal that Elmo1 and Elmo2 proteins promote the cytoplasmic localization of Med31, dependent upon the C-terminal PxxP motif-mediated binding to Med31.
Med31 and Elmo1
Are Required for Specific Gene Expression of Il33 and Il10 during Salmonella Infection Previously, in a Drosophila cell culture model, dMed31 was shown to be required for expression of lipopolysaccharide (LPS)-and heat shock-activated endogenous genes but dispensable for transcription of synthetic promoters [19] . Recent studies have also revealed that BAI1, the membrane receptor upstream of Elmo1, can engage the LPS of Gramnegative bacteria [6] , and that the BAI1:Elmo1 module can mediate uptake of these bacteria into macrophages. Therefore, we asked whether murine Med31 and Elmo1 play a role in LPS-activated gene expression in primary bone marrowderived macrophages (BMDMs). We performed small interfering RNA (siRNA) Figure 3A ). siRNA knockdown of Elmo1 did not result in the compensatory upregulation of Elmo2 (Table S1A) observed in BMDMs isolated from Elmo1-deficient mice [20] , nor were Elmo3 transcript levels affected (Table S1A ). The siRNA-transfected BMDMs were then infected with the Gram-negative enteric pathogen Salmonella enterica serovar Typhimurium (with a DinvG bacterial strain that depends on Bai1-Elmo1-dependent cellular entry). After 6 hr, we profiled the BMDMs for 25 different gene transcripts, including genes encoding for cytokines, transcription factors, and cell-cycle regulators via quantitative RT-PCR (qRT-PCR) (Table S1B) . We categorized the genes into three groups based on change in expression after Salmonella infection: genes whose expression was upregulated >2-fold from uninfected BMDMs, those whose expression was lowered >2-fold from uninfected BMDMs, and those that had no change in expression after infection.
Among the 12 genes upregulated during Salmonella infection (Table S1B) , two genes encoding cytokines interleukin 33 (IL-33) and interleukin 10 (IL-10) were particularly sensitive to loss of Elmo1 and Med31. Basally, Il33 transcript levels were not detectable in uninfected BMDMs, but Il33 expression was increased following Salmonella infection ( Figure 3B ). Knockdown of Med31 reduced the upregulation of Il33 by >50%; similarly, knockdown of Elmo1 also decreased Il33 expression >50% after Salmonella infection ( Figure 3B ). BMDMs express low levels of Il10 transcripts in the uninfected state, but infection results in a >15-fold increase in Il10 expression ( Figure 3B ). Knockdown of either Med31 or Elmo1 inhibited the upregulation of Il10 ( Figure 3B ). Interestingly, concurrent knockdown of both Med31 and Elmo1 did not further decrease the transcript levels of Il33 or Il10 ( Figure 3B ). One likely explanation is that Elmo1 and Med31 might function in the same pathway downstream of Salmonella infection. This requirement of Elmo1 and Med31 for upregulation of Il33 and Il10 cytokine genes after Salmonella infection appeared specific, because their knockdown did not affect upregulation of the gene encoding tumor necrosis factor (Tnf) ( Figure 3C) .
Importantly, knockdown of Elmo1 and Med31 did not affect the basal transcript level of any of the genes analyzed; similarly, the transcript levels of genes that were downregulated GAPDH was used as a cytoplasmic marker, p53 as a nuclear marker, and b-actin as a loading control. Scale bars in (A) and (J) represent 10 mm and apply to (A)-(X). See also Figure S2 .
(four genes) or unchanged (nine genes) in response to Salmonella infection (Table S1B) were also unaffected by loss of Elmo1 or Med31. All cytokine genes measured were upregulated following infection, with the exception of the gene encoding transforming growth factor b1 (Tgfb1), whose expression was unchanged ( Figure 3C ). Three of the four genes that were downregulated after infection encode transcription factors, including the nuclear factor of activated T cells (NFAT)c1 gene (Nfatc1) ( Figure 3C ). Knockdown of Elmo1, Med31, or both had no effect on Tgfb1 or Nfatc1 gene expression, suggesting that siRNA knockdown of Elmo1 and Med31 does not impact transcription globally. Interestingly, all three genes unaffected by the siRNA knockdown of Elmo1 and Med31 (Tnf, Tgfb1, and Nfatc1) have high levels of basal expression in the uninfected state; because RNA polymerase II-dependent transcription requires the Mediator complex, these data suggest Med31 is dispensable for expression of some genes and that separate regulatory mechanisms likely exist for basal and activated gene transcription.
Elmo1 Promotes the Ubiquitination of Med31
Elmo1 binding has been linked to modification of the ubiquitination state of Dock180, wherein coexpression of Elmo1 Table S1B. with Dock180 decrease the polyubiquitination state of Dock180 and in turn improve the stability/half-life of Dock180 [21] . We asked whether the Med31 ubiquitination status might be influenced by Elmo1. Surprisingly, the overall ubiquitination status of Med31 was increased when coexpressed with Elmo1 ( Figure 4A ). Based on the predicted molecular weight of proteins migrating on SDS-PAGE, we observed two prominent bands that corresponded to mono-and diubiquitinated Med31 [Med31-Ub and Med31-(Ub) 2 , respectively], in addition to higher polyubiquitinated forms ( Figure 4A ). Whereas polyubiquitination (more than four ubiquitin moieties) is often linked to proteasomal degradation of the ubiquitin-modified protein [22] , mono-and diubiquitination have been linked to signaling (e.g., in gene transcription via NF-kB) [23] [24] [25] .
Whereas increased levels of diubiquitinated Med31-(Ub) 2 were observed with coexpression of both Elmo1 and Elmo1 AxxA ( Figure 4A ), monoubiquitinated Med31 was present at higher levels when coexpressed with wild-type Elmo1. As further support that Elmo1:Med31 binding regulates Med31 ubiquitination status, the Elmo1 AxxA mutant did not increase the monoubiquitinated form ( Figure 4A ). When we examined the subcellular localization of ubiquitinated forms of Med31, Med31-Ub was found primarily in the cytoplasm ( Figure 4B ), whereas Med31-(Ub) 2 was readily detectable in both cytoplasmic and nuclear fractions ( Figure 4B ). Coexpression with either full-length or the C-terminal portion of Elmo1 resulted in increased cytoplasmic Med31-Ub, whereas an N-terminal mutant of Elmo1 that lacks the PxxP motif did not ( Figure 4B ). Collectively, these results reveal that Elmo proteins that interact with Med31 can promote the monoubiquitination of Med31 in the cytoplasmic fractions.
Because ubiquitination occurs at lysine residues, we aligned the Med31 protein sequences from yeast to human ( Figure S3 ), mutated the two conserved lysine residues within the central consensus sequence to arginine residues (K44R and K53R), and tested whether they would inhibit ubiquitination of Med31. Unfortunately, mutation of these two conserved lysine residues did not disrupt the ubiquitination of Med31 (data not shown), suggesting that ubiquitination may occur at a nonconserved lysine residue in murine Med31, or that perhaps compensatory ubiquitination may occur at more than one site on Med31.
Collectively, the data presented in this report provide several interesting observations. First, this work identifies cytoplasmic Elmo1 as a previously unrecognized partner of the Med31 subunit of the Mediator complex. Second, Elmo1 alters the cytoplasmic versus nuclear distribution of Med31. Third, we identify a previously unknown posttranslational modification of Med31, and the monoubiquitinated form is modified by Elmo1. Fourth, in a physiological context where Elmo1 has previously been shown to play a role, Med31 and Elmo1 are required for the activated expression of the same subset of genes in primary macrophages; in particular, during the response of immune cells to Salmonella infection, both Elmo1 and Med31 influence the same set of genes, suggesting a possible conserved role for Med31 in LPS-activated gene expression. Interestingly, among the >25 genes analyzed, Elmo1 and Med31 were required for transcription of the cytokine genes Il33 and Il10, suggesting a specificity in the expression of genes controlled by these two molecules.
The Mediator complex has been reported to include over 30 subunits, and many subunits are believed to influence a distinct subset of genes through their myriad protein-protein interactions with non-Mediator complex proteins [11, 14] , but the role of cytoplasmic proteins in regulating specific Mediator subunits has been unclear. Given the striking cytoplasmic relocalization of Med31 when coexpressed with Elmo1, our initial hypothesis was that Elmo1 might affect Med31-dependent gene transcription by sequestering Med31 in the cytoplasm. Our siRNA studies in macrophages are inconsistent with a simple sequestration model. Although our mutational studies were unsuccessful in identifying the specific lysine residues ubiquitinated on Med31, future studies targeting multiple lysines might provide insights on how ubiquitination may influence Med31 interactions with other components of the Mediator complex. Given that Elmo1 and Med31 (as well as the Mediator complex) are highly evolutionarily conserved, this work suggests new considerations on the regulation of specific genes during biological processes, including pathogen-induced gene transcription.
Experimental Procedures
Preparation of Bone Marrow-Derived Macrophages and Salmonella Infection All mouse experiments were performed according to protocols approved by the Animal Care and Use Committee of the University of Virginia. Bone marrow-derived macrophages were generated from C57BL/6 donor mice as described previously [26] and were maintained in differentiation medium consisting of Dulbecco's modified Eagle's medium with 10% fetal bovine serum, 10% L929-conditioned media, and antibiotics. Using an Amaxa mouse macrophage nucleofector kit (Lonza), BMDMs were transfected with a siGENOME SMARTpool containing four siRNAs targeting mouse Elmo1 (M-041254-00, Dharmacon) and/or Med31 (M-047061-01) and then incubated for 48 hr to recover; total siRNA was kept constant with siGE-NOME nontargeting siRNA pool #2 (D-001206-14) . siRNA-transfected BMDMs were plated at 1.0 3 10 5 cells per well in 96-well plates and infected with Salmonella enterica serovar Typhimurium (DinvG) as described previously [6] . BMDM mRNA was isolated 6 hr postinfection using an RNeasy kit (QIAGEN). cDNA was generated from isolated mRNA using random primers and a SuperScript III First-Strand Synthesis kit (Life Technologies). Transcript levels were measured by qRT-PCR using TaqMan gene expression assays (see Supplemental Experimental Procedures) and a One-Step Plus RT-PCR instrument (Life Technologies). Results were normalized to transcripts of the reference gene Hprt1.
Please see Supplemental Experimental Procedures for detailed materials and methods.
Supplemental Information
Supplemental Information includes three figures, one Immunoblotting of GST precipitations from cytoplasmic and nuclear extracts of cells expressing HA-ubiquitin, GST-Med31, Elmo1-FLAG, or Elmo1 truncation mutants 1-558 and 532-727 is shown. Monoubiquitinated Med31-Ub was primarily found within the cytoplasmic extract, whereas Med31-(Ub) 2 was observed within both cytoplasmic and nuclear extracts. Coexpression of Med31 with either the full-length (1-727) or PxxP-containing fragment (532-727) of Elmo1 enhanced the levels of both cytoplasmic Med31-Ub and nuclear Med31-(Ub) 2 compared to coexpression with a PxxP-deletion mutant of Elmo1 (1-558).
